131 related articles for article (PubMed ID: 2910546)
1. Predicting ventricular tachycardia cycle length after procainamide by assessing cycle length-dependent changes in paced QRS duration.
Marchlinski FE; Buxton AE; Josephson ME; Schmitt C
Circulation; 1989 Jan; 79(1):39-46. PubMed ID: 2910546
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
3. Procainamide-induced changes in reentrant ventricular tachycardia with special reference to the tachycardia-interrupting critical paced cycle length during transient entrainment with rapid pacing.
Aizawa Y; Naitoh N; Washizuka T; Kitazawa H; Takahashi K; Kodama I; Shibata A
Jpn Heart J; 1994 Sep; 35(5):611-23. PubMed ID: 7830326
[TBL] [Abstract][Full Text] [Related]
4. Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias.
Marchlinski FE; Buxton AE; Kindwall KE; Miller JM; Rosenthal ME; Gottlieb CD; Bloom RB; Josephson ME
Circulation; 1988 Sep; 78(3):583-91. PubMed ID: 3409498
[TBL] [Abstract][Full Text] [Related]
5. Procainamide induced change of the width of the zone of entrainment and its relation to the inducibility of reentrant ventricular tachycardia.
Aizawa Y; Tanabe Y; Naitoh N; Washizuka T; Shibata A; Josephson ME
Pacing Clin Electrophysiol; 1997 Nov; 20(11):2789-98. PubMed ID: 9392810
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of procainamide on ventricular tachycardia: relation to prolongation of refractoriness and slowing of conduction.
Furukawa T; Rozanski JJ; Moroe K; Gosselin AJ; Lister JW
Am Heart J; 1989 Oct; 118(4):702-8. PubMed ID: 2801477
[TBL] [Abstract][Full Text] [Related]
7. Frequency and output-dependent change in conduction over slow pathways in a patient with sustained ventricular tachycardia unrelated to coronary artery disease.
Chinushi M; Aizawa Y; Funazaki T; Tamura M; Shibata A
Pacing Clin Electrophysiol; 1992 May; 15(5):756-61. PubMed ID: 1382278
[TBL] [Abstract][Full Text] [Related]
8. Effects of lidocaine and procainamide on normal and abnormal intraventricular electrograms during sinus rhythm.
Schmitt CG; Kadish AH; Marchlinski FE; Miller JM; Buxton AE; Josephson ME
Circulation; 1988 May; 77(5):1030-7. PubMed ID: 3359584
[TBL] [Abstract][Full Text] [Related]
9. Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia.
Grimm W; Cho JG; Marchlinski FE
J Cardiovasc Electrophysiol; 1994 Apr; 5(4):313-22. PubMed ID: 8019707
[TBL] [Abstract][Full Text] [Related]
10. Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone.
Vaitkus PT; Buxton AE; Josephson ME; Marchlinski FE
Am J Cardiol; 1990 Sep; 66(7):710-4. PubMed ID: 2399887
[TBL] [Abstract][Full Text] [Related]
11. Prediction of antiarrhythmic efficacy of class I and III agents in patients with ventricular tachycardia by signal-averaged ECG analysis.
Kulakowski P; Bashir Y; Heald S; Paul V; Anderson MH; Gibson S; Malik M; Camm AJ
Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2116-21. PubMed ID: 1279610
[TBL] [Abstract][Full Text] [Related]
12. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
Kus T; Costi P; Dubuc M; Shenasa M
Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
[TBL] [Abstract][Full Text] [Related]
13. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
Kidwell GA; Greenspon AJ; Greenberg RM; Volosin KJ
Circulation; 1993 Jan; 87(1):118-25. PubMed ID: 8418998
[TBL] [Abstract][Full Text] [Related]
14. Diastolic potentials recorded by surface electrocardiographic signal averaging during sustained ventricular tachycardia: possible origin from the reentrant circuit.
Kremers MS; Hsia H; Wells P; Black W; Solo M; Albert D
Pacing Clin Electrophysiol; 1991 Jun; 14(6):1000-6. PubMed ID: 1715059
[TBL] [Abstract][Full Text] [Related]
15. Preferential effect of procainamide on the reentrant circuit of ventricular tachycardia.
Kay GN; Epstein AE; Plumb VJ
J Am Coll Cardiol; 1989 Aug; 14(2):382-90. PubMed ID: 2754127
[TBL] [Abstract][Full Text] [Related]
16. Periodic changes in cycle length of ventricular tachycardia: a Wenckebach type exit block?
Aizawa Y; Funazaki T; Satoh M; Suzuki K; Aizawa M; Shibata A
J Electrocardiol; 1986 Oct; 19(4):389-92. PubMed ID: 2432142
[TBL] [Abstract][Full Text] [Related]
17. In vivo induction of "focal" triggered ventricular arrhythmias and responses to overdrive pacing in the canine heart.
Furukawa T; Kimura S; Catstellanos A; Bassett AL; Myerburg RJ
Circulation; 1990 Aug; 82(2):549-59. PubMed ID: 2372901
[TBL] [Abstract][Full Text] [Related]
18. Rate-dependent effects of intravenous lidocaine, procainamide and amiodarone on intraventricular conduction.
Morady F; DiCarlo LA; Baerman JM; Krol RB
J Am Coll Cardiol; 1985 Jul; 6(1):179-85. PubMed ID: 4008772
[TBL] [Abstract][Full Text] [Related]
19. Alternation in the fusion complex during constant pacing of sustained ventricular tachycardia.
Chinushi M; Aizawa Y; Kusano Y; Kitazawa H; Miyajima T; Shibata A
Jpn Heart J; 1993 Mar; 34(2):227-34. PubMed ID: 8315820
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
Aizawa Y; Chinushi M; Naitoh N; Shibata A
Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
